Fidelity Investments’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,496,096
Closed -$10.8M 5652
2023
Q1
$10.8M Sell
1,496,096
-381,700
-20% -$2.96M ﹤0.01% 1845
2022
Q4
$15.4M Sell
1,877,796
-848,668
-31% -$7.91M ﹤0.01% 1721
2022
Q3
$28.8M Buy
2,726,464
+916,381
+51% +$9.74M ﹤0.01% 1481
2022
Q2
$16.7M Buy
1,810,083
+1,712,749
+1,760% +$14M ﹤0.01% 1721
2022
Q1
$670K Buy
+97,334
New +$627K ﹤0.01% 2899
2021
Q3
Sell
-1
Closed 5249
2021
Q2
$0 Buy
+1
New +$4 ﹤0.01% 5091
2020
Q3
Sell
-4,518,599
Closed -$46.5M 4101
2020
Q2
$46.5M Buy
4,518,599
+7,450
+0.2% +$75.5K 0.01% 1196
2020
Q1
$45M Buy
4,511,149
+357,750
+9% +$3.19M 0.01% 1073
2019
Q4
$31.5M Buy
4,153,399
+99,022
+2% +$677K ﹤0.01% 1410
2019
Q3
$25.9M Buy
+4,054,377
New +$28.6M ﹤0.01% 1475

Other funds holding BLU

Fidelity Investments's BLU Position: Q2 2023 in Review

Fidelity Investments sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 1,496,096 shares — an estimated $10.8M sold.

Fidelity Investments first reported a position in BLU in Q3 2019 and held it in 10 quarters. The position peaked at $46.5M in Q2 2020. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Fidelity Investments reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Fidelity Investments sold 1,496,096 BELLUS Health Inc. shares in Q2 2023, an estimated $10.8M.
  • Fidelity Investments first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 10 quarters.
  • Fidelity Investments's BELLUS Health Inc. position peaked at $46.5M in Q2 2020.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.